Article Details

Engineered single-domain antibodies tackle COVID variants

Retrieved on: 2021-06-30 16:41:15

Tags for this article:

Click the tags to see associated articles and topics

Engineered single-domain antibodies tackle COVID variants. View article details on hiswai:

Excerpt

Human monoclonal antibodies are strongly preferred for clinical development because they are highly specific, are easily manufactured and work in ...

Article found on: www.nature.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo